Literature DB >> 47091

Disorders of blood-lipids in renal disease.

D G Cramp, J F Moorhead, M R Wills.   

Abstract

Hyperlipidaemia is a characteristic feature not only of the nephrotic syndrome but also of chronic renal disease without the features of that syndrome. There is evidence for disordered lipid metabolism in patients with chronic renal disease. In these patients the disordered lipid metabolism, the precise cause of which is unknown, is characterised by hypertriglyceridaemia, the aetiology of which is probably multifactorial. Hyperlipidaemia is an important potential risk factor in the aetiology of cardiovascular disease, which may be a leading cause of death in patients undergoing long-term maintenance haemodialysis therapy.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 47091     DOI: 10.1016/s0140-6736(75)91770-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  5 in total

Review 1.  Coronary heart disease in diabetes mellitus--antecedents and associations.

Authors:  P H Winocour
Journal:  Postgrad Med J       Date:  1991-10       Impact factor: 2.401

2.  Effect of endogenous metabolites on the binding of o-methyl red to human serum albumin [proceedings].

Authors:  C J Bowmer; W E Lindup
Journal:  Br J Pharmacol       Date:  1976-10       Impact factor: 8.739

3.  Hormone-fuel concentrations in anephric subjects. Effect of hemodialysis (with special reference to amino acids).

Authors:  O P Ganda; T T Aoki; J S Soeldner; R S Morrison; G F Cahill
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

4.  Acute colitis in the renal allograft recipient.

Authors:  L J Perloff; H Chon; E J Petrella; R A Grossman; C F Barker
Journal:  Ann Surg       Date:  1976-01       Impact factor: 12.969

5.  Factors in the differential rate of arteriosclerosis (AS) between long surviving renal transplant recipients and dialysis patients.

Authors:  F T Thomas; H M Lee
Journal:  Ann Surg       Date:  1976-09       Impact factor: 12.969

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.